Krystal Biotech, Inc.
Status: Publicly traded
Direct answer
Krystal Biotech, Inc. is publicly traded on NASDAQ under the ticker KRYS.
Krystal Biotech, Inc. is a clinical-stage biotechnology company focused on developing redosable gene therapies to address severe orphan diseases across the United States. Its most advanced therapeutic candidate, beremagene geperpavec (B-VEC), is currently undergoing Phase III clinical evaluation for the treatment of dystrophic epidermolysis bullosa. The company's pipeline also includes several other promising...
Can you invest in Krystal Biotech, Inc.?
Yes. Krystal Biotech, Inc. trades publicly on NASDAQ as KRYS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Krystal Biotech, Inc.
Detailed equity research is provided by MarketSnap.